tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Toxocariasis D014120 3 associated lipids
Translocation, Genetic D014178 20 associated lipids
Tremor D014202 15 associated lipids
Trichomonas Infections D014245 3 associated lipids
Trichomonas Vaginitis D014247 2 associated lipids
Trypanosomiasis D014352 5 associated lipids
Tuberous Sclerosis D014402 2 associated lipids
Ulcer D014456 16 associated lipids
Uremia D014511 33 associated lipids
Urinary Tract Infections D014552 11 associated lipids
Urination Disorders D014555 9 associated lipids
Urticaria D014581 13 associated lipids
Uveitis D014605 14 associated lipids
Uveitis, Anterior D014606 11 associated lipids
Uveomeningoencephalitic Syndrome D014607 1 associated lipids
Vascular Diseases D014652 16 associated lipids
Vasculitis D014657 14 associated lipids
Venous Insufficiency D014689 2 associated lipids
Viremia D014766 4 associated lipids
Vision Disorders D014786 10 associated lipids
Vitiligo D014820 2 associated lipids
Vomiting D014839 21 associated lipids
West Nile Fever D014901 1 associated lipids
Wounds, Stab D014951 3 associated lipids
Dementia, Vascular D015140 7 associated lipids
Cholangitis, Sclerosing D015209 1 associated lipids
Inflammatory Bowel Diseases D015212 9 associated lipids
Carcinoma, Merkel Cell D015266 2 associated lipids
Churg-Strauss Syndrome D015267 2 associated lipids
Tumor Lysis Syndrome D015275 2 associated lipids
Discitis D015299 2 associated lipids
Dry Eye Syndromes D015352 10 associated lipids
Scleritis D015423 3 associated lipids
Reperfusion Injury D015427 65 associated lipids
Weight Gain D015430 101 associated lipids
Weight Loss D015431 56 associated lipids
Glomerulonephritis, Membranoproliferative D015432 3 associated lipids
Glomerulonephritis, Membranous D015433 6 associated lipids
Panniculitis, Lupus Erythematosus D015435 1 associated lipids
Leprosy, Borderline D015439 3 associated lipids
Leukemia, Biphenotypic, Acute D015456 2 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Leukemia, Myelogenous, Chronic, BCR-ABL Positive D015464 17 associated lipids
Leukemia, Myeloid, Chronic-Phase D015466 1 associated lipids
Paraparesis, Tropical Spastic D015493 1 associated lipids
Histiocytosis D015614 2 associated lipids
HIV Infections D015658 20 associated lipids
Osteoporosis, Postmenopausal D015663 4 associated lipids
Eye Diseases, Hereditary D015785 1 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Kakefuda T et al. Nitrosyl hemoglobin detected by near-infrared spectroscopy in rat liver allografts. 1999 Transpl. Int. pmid:10551995
Chen L et al. Bastadin 10 stabilizes the open conformation of the ryanodine-sensitive Ca(2+) channel in an FKBP12-dependent manner. 1999 J. Biol. Chem. pmid:10551814
Zoppo A et al. Trimetazidine counteracts tacrolimus nephrotoxicity in a hypertensive liver transplant patient. 1999 Transplantation pmid:10551656
Pirsch JD Cytomegalovirus infection and posttransplant lymphoproliferative disease in renal transplant recipients: results of the U.S. multicenter FK506 Kidney Transplant Study Group. 1999 Transplantation pmid:10551653
Rolles K et al. A pilot study of immunosuppressive monotherapy in liver transplantation: tacrolimus versus microemulsified cyclosporin. 1999 Transplantation pmid:10551650
Ocran KW et al. Tacrolimus toxicity due to drug interaction with mibefradil in a patient after liver transplantation. 1999 Z Gastroenterol pmid:10549098
Dubernard JM et al. [The first transplantation of a hand in humans. Early results]. 1999 Chirurgie pmid:10546388
Klein A Tacrolimus rescue in liver transplant patients with refractory rejection or intolerance or malabsorption of cyclosporine. The US Multicenter FK506 Liver Study Group. 1999 Liver Transpl Surg pmid:10545538
Himukai R et al. Relationship between the subcellular localization and structures of catalytic domains of FKBP-type PPIases. 1999 J. Biochem. pmid:10544281
Wiedeman PE et al. Retention of immunosuppressant activity in an ascomycin analogue lacking a hydrogen-bonding interaction with FKBP12. 1999 J. Med. Chem. pmid:10543889
Pearlman DA Free energy grids: a practical qualitative application of free energy perturbation to ligand design using the OWFEG method. 1999 J. Med. Chem. pmid:10543875
Aoki Y and Kao PN Erythromycin inhibits transcriptional activation of NF-kappaB, but not NFAT, through calcineurin-independent signaling in T cells. 1999 Antimicrob. Agents Chemother. pmid:10543746
Matsuda J [Tacrolimus hydrate (tacrolimus)]. 1999 Nippon Rinsho pmid:10543146
Capone D et al. Effects of itraconazole on tacrolimus blood concentrations in a renal transplant recipient. 1999 Ann Pharmacother pmid:10534229
Mistríková J et al. Increased neoplasm development due to immunosuppressive treatment with FK-506 in BALB/C mice persistently infected with the mouse herpesvirus (MHV-72). 1999 Viral Immunol. pmid:10532652
Leroy-Matheron C et al. Inhibitor against coagulation factor V after liver transplantation. 1999 Transplantation pmid:10532550
Migita K et al. FK506 markedly enhances apoptosis of antigen-stimulated peripheral T cells by down-regulation of Bcl-xL. 1999 Transplantation pmid:10532544
Ellis D et al. Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression. 1999 Transplantation pmid:10532541
Morris-Stiff G et al. Immunosuppression in renal transplantation. Meta-analysis should not have included one of the studies. 1999 BMJ pmid:10531121
Minematsu T et al. Sustained QT prolongation induced by tacrolimus in guinea pigs. 1999 Life Sci. pmid:10530807
Okada M et al. Successful treatment of chronic graft-versus-host disease with sulfasalazine in allogeneic bone marrow transplantation. 1999 Acta Haematol. pmid:10529517
Morita H et al. Immunosuppressive effect of leukotriene B(4) receptor antagonist in vitro. 1999 Biochem. Biophys. Res. Commun. pmid:10529362
Cannon RD et al. Clinical efficacy of the Abbott Tacrolimus II assay for the IMx. 1999 Oct-Dec Ann. Clin. Lab. Sci. pmid:10528829
Grimbert P et al. Tacrolimus (FK506)-induced severe and late encephalopathy in a renal transplant recipient. 1999 Nephrol. Dial. Transplant. pmid:10528682
Shadidy M et al. Biochemical analysis of mouse FKBP60, a novel member of the FKPB family. 1999 Biochim. Biophys. Acta pmid:10524204
Lee SF et al. Cytokine receptor common beta chain as a potential activator of cytokine withdrawal-induced apoptosis. 1999 Mol. Cell. Biol. pmid:10523628
Mao Z and Wiedmann M Calcineurin enhances MEF2 DNA binding activity in calcium-dependent survival of cerebellar granule neurons. 1999 J. Biol. Chem. pmid:10521511
Hübner GI et al. Drug interaction between mycophenolate mofetil and tacrolimus detectable within therapeutic mycophenolic acid monitoring in renal transplant patients. 1999 Ther Drug Monit pmid:10519451
Yoshimoto T and Siesjö BK Posttreatment with the immunosuppressant cyclosporin A in transient focal ischemia. 1999 Brain Res. pmid:10519051
Pacocha SE et al. Regulation of antigen-induced human T-lymphocyte responses by calcineurin antagonists. 1999 J. Allergy Clin. Immunol. pmid:10518828
Bekersky I et al. Bioequivalence of 1 and 5 mg tacrolimus capsules using a replicate study design. 1999 J Clin Pharmacol pmid:10516937
Przepiorka D et al. Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation. 1999 Bone Marrow Transplant. pmid:10516680
Moore JM NMR techniques for characterization of ligand binding: utility for lead generation and optimization in drug discovery. 1999 Biopolymers pmid:10516573
Cardenas ME et al. Antifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug action. 1999 Clin. Microbiol. Rev. pmid:10515904
Cunningham EB An inositolphosphate-binding immunophilin, IPBP12. 1999 Blood pmid:10515881
Fan L et al. Improved artificial death switches based on caspases and FADD. 1999 Hum. Gene Ther. pmid:10515447
Charney DA et al. Plasma cell-rich acute renal allograft rejection. 1999 Transplantation pmid:10515379
Rostaing L et al. Differences in Type 1 and Type 2 intracytoplasmic cytokines, detected by flow cytometry, according to immunosuppression (cyclosporine A vs. tacrolimus) in stable renal allograft recipients. 1999 Clin Transplant pmid:10515221
Robinson BV et al. Optimal dosing of intravenous tacrolimus following pediatric heart transplantation. 1999 J. Heart Lung Transplant. pmid:10512526
Dusting GJ et al. Cyclosporin A and tacrolimus (FK506) suppress expression of inducible nitric oxide synthase in vitro by different mechanisms. 1999 Br. J. Pharmacol. pmid:10510443
Böttiger Y et al. Tacrolimus whole blood concentrations correlate closely to side-effects in renal transplant recipients. 1999 Br J Clin Pharmacol pmid:10510159
Lee WP and Mathes DW Hand transplantation: pertinent data and future outlook. 1999 J Hand Surg Am pmid:10509267
Sche PP et al. Display cloning: functional identification of natural product receptors using cDNA-phage display. 1999 Chem. Biol. pmid:10508685
Chautan M et al. Interdigital cell death can occur through a necrotic and caspase-independent pathway. 1999 Curr. Biol. pmid:10508592
Tredger JM et al. Performance of the IMx tacrolimus II assay and practical limits of detection. 1999 Clin. Chem. pmid:10508145
Cao Z et al. Comparison of tacrolimus concentrations measured by the IMx tacrolimus II vs the PRO-TRAC II FK506 ELISA assays. 1999 Clin. Chem. pmid:10508139
Cacciarelli TV et al. An analysis of pretransplantation variables associated with long-term allograft outcome in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. 1999 Transplantation pmid:10507484
Letko E et al. Tacrolimus (FK 506). 1999 Ann. Allergy Asthma Immunol. pmid:10507260
Linder MW and Elin RJ Implications of methodologic bias for therapeutic drug monitoring. 1999 Arch. Pathol. Lab. Med. pmid:10506447
Yoshimura R et al. The effect of immunosuppressive agents (FK-506, rapamycin) on renal P450 systems in rat models. 1999 J. Pharm. Pharmacol. pmid:10504034